Qilian International (QLI) - Long-Term Debt to Capital

The daily price chart for Qilian International (QLI) is based on the sales of chemical components and traditional Chinese medicines through hospitals and pharmacies, with the metric standing at 0.00. Entry into this niche is restricted by patents and stringent oversight from PRC authorities. Business stability is ensured by an autonomous internal cycle and sustained interest in medical research, transforming the asset into a reliable defensive tool for capital protection.

Investors must find a balance between operational returns and debt burden. Qilian International (QLI) owns autonomous plants but remains critically dependent on external raw material suppliers. The trend in the long-term debt-to-equity ratio demonstrates the relationship between liabilities exceeding one year and net assets. An increase in this coefficient signals that expansion is fueled by excessive borrowing. Low leverage confirms financial stability and production independence.